UNLIMITED TURBO BULL - IPSEN | Real-time Euronext Paris 04:08:00 2024-04-29 EDT | ||
| 2.325 EUR | -0.85% |
|
| Current month | +4.92% | ||
| 1 month | +10.87% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-29 | 2.325 | -0.85% | 12 |
| 24-04-26 | 2.345 | +2.63% | 44 |
| 24-04-25 | 2.285 | -1.30% | 59 |
| 24-04-24 | 2.315 | +1.76% | 50 |
| 24-04-23 | 2.275 | -1.30% | 50 |
Real-time Euronext Paris
Last update April 29, 2024 at 04:08 am
More quotesStatic data
| Product type | Certificat Turbo Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | 
Société Générale
|
| 7E06S | |
| ISIN | DE000CL89UP7 |
| Date issued | 2020-04-24 |
| Strike | 66.52 € |
| Maturity | Unlimited |
| Parity | 20 : 1 |
| Emission price | 0.48 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.395 € |
|---|---|
| Lowest since issue | 0.43 € |
| Spread | 0.04 € |
| Spread % | 1.69% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
113
EUR
Average target price
125.1
EUR
Spread / Average Target
+10.70%
- Stock Market
- Certificates
- 7E06S Certificat
